UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057332
Receipt number R000065530
Scientific Title Registry-based Research of Extracellular Volume Fraction (ECV) Assessed by Cardiac CT in patients with cardiovascular disease
Date of disclosure of the study information 2025/03/19
Last modified on 2025/03/18 22:33:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Registry-based Research of Extracellular Volume Fraction (ECV) Assessed by Cardiac CT in patients with cardiovascular disease

Acronym

Observational Study on Extracellular Volume using Cardiac CT

Scientific Title

Registry-based Research of Extracellular Volume Fraction (ECV) Assessed by Cardiac CT in patients with cardiovascular disease

Scientific Title:Acronym

Observational Study on Extracellular Volume using Cardiac CT

Region

Japan


Condition

Condition

Cardiovascular disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Myocardial fibrosis and edema are recognized as pathological changes in a wide range of cardiac conditions, including coronary artery disease and cardiomyopathies. Accurate assessment of these changes is known to be useful for diagnosing heart diseases and predicting their prognosis. Extracellular volume fraction (ECV), measured non-invasively, has been established as a valuable indicator for evaluating the extent of myocardial fibrosis or edema. This study aims to investigate the relationship between ECV assessed by cardiac CT and patient characteristics, as well as findings from other invasive and non-invasive examinations (including echocardiography, coronary angiography, and myocardial biopsy). By clarifying the diagnostic utility, risk stratification potential, therapeutic efficacy assessment, and prognostic value of ECV in heart diseases, this study seeks to contribute to the optimization of individualized disease prevention and treatment strategies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

None

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent a cardiac CT scan for a detailed evaluation of heart disease and were eligible for ECV assessment.

Key exclusion criteria

Patients for whom cardiac CT and its corresponding ECV assessment cannot be performed.

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Tsunekazu
Middle name
Last name Kakuta

Organization

Tsuchiura Kyodo General Hospital

Division name

Department of Cardiovascular Medicine

Zip code

300-0028

Address

4-1-1, Otsuno, Tsuchiura, Ibaraki, Japan

TEL

+81-29-830-3711

Email

kaz@joy.email.ne.jp


Public contact

Name of contact person

1st name Yoshihisa
Middle name
Last name Kanaji

Organization

Tsuchiura Kyodo General Hospital

Division name

Department of Cardiovascular Medicine

Zip code

300-0028

Address

4-1-1, Otsuno, Tsuchiura, Ibaraki, Japan

TEL

+81-29-830-3711

Homepage URL


Email

yoshihisa.kanaji@gmail.com


Sponsor or person

Institute

Tsuchiura Kyodo General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Tsuchiura Kyodo General Hospital

Address

4-1-1, Otsuno, Tsuchiura, Ibaraki, Japan

Tel

+81-29-830-3711

Email

general@tkgh.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 02 Month 01 Day

Date of IRB

2025 Year 02 Month 18 Day

Anticipated trial start date

2025 Year 03 Month 18 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A registry-based study encompassing both retrospective data from cardiac CT scans performed since 2023 and prospective data from future cardiac CT examinations.


Management information

Registered date

2025 Year 03 Month 18 Day

Last modified on

2025 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065530